References
- World Health Organization (WHO). WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: WHO; 2007.
- O'Neil KM. The changing landscape of HIV-related lung disease in the era of highly active antiretroviral therapy. Chest 2002;122:768-71.
- Beck JM, Rosen MJ, Peavy HH. Pulmonary complications of HIV infection: report of the fourth NHLBI workshop. Am J Respir Crit Care Med 2001;164:2120-6.
- Taylor IK, Coker RJ, Clarke J, Moss FM, Nieman R, Evans DJ, Veale D, Shaw RJ, Robinson DS, Mitchell DM. Pulmonary complications of HIV disease: 10 year retrospective evaluation of yields from bronchoalveolar lavage, 1983-93. Thorax 1995;50:1240-5.
- Rosen MJ. Overview of pulmonary complications. Clin Chest Med 1996;17:621-31.
- Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 2010;50(Suppl. 3):S201-7.
- Mugusi FM, Mehta S, Villamor E, Urassa W, Saathoff E, Bosch RJ, Fawzi WW. Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health 2009;9:409.
- Lazarus JV, Olsen M, Ditiu L, Matic S. Tuberculosis-HIV co-infection: policy and epidemiology in 25 countries in the WHO European region. HIV Med 2008;9:406-14.
- Albino JA, Shapiro JM. Early bronchoscopic diagnosis of concomitant tuberculosis and Pneumocystis carinii pneumonia in patients with HIV infection. J Assoc Acad Minor Phys 1996;7:9-103.
- van Heese AH, Risseeuw GA. Pneumocystis carinii pneumonia in a HIV-positive patient. JBR-BTR 2010;93:154-5.
- Saldana MJ, Mones JM. Pulmonary pathology in AIDS: atypical Pneumocystis carinii infection and lymphoid interstitial pneumonia. Thorax 1994;49(Supplement): S46-55.
- Golden JA, Hollander H, Stulbarg MS, Gamsu G. Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome. Chest 1986;90:18-22.
- Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristerà R, Aiuti F, Ortona L, Ensoli B. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 1999;91:1468-74.
- Mitsuyasu RT. AIDS-related Kaposi's sarcoma: current treatment options, future trends. Oncology (Williston Park) 2000;14:867-78.
- Wallace JM, Hansen NI, Lavange L, Glassroth J, Browdy BL, Rosen MJ, Kvale PA, Mangura BT, Reichman LB, Hopewell PC. Respiratory disease trends in the pulmonary complications of HIV infection study cohort. Pulmonary complications of HIV infection study group. Am J Respir Crit Care Med 1997;155:72-80.
- de Lalla F, Vaglia A, Franzetti M, Manfrin V, Pellizzer GP, Fabris P. Cryptococcal pleural effusion as first indicator of AIDS: a case report. Infection 1993;21:192.
- Uberti-Foppa C, Lillo F, Terreni MR, Puglisi A, Guffanti M, Gianotti N, Lazzarin A. Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease. Chest 1998;113:919-23.
- Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA 1998;279:35-40.
- Nemeth Blažić T. Epidemiologija HIV infekcije i AIDS-a u Hrvatskoj [Epidemiology of HIV-infection and AIDS in Croatia, in Croatian]. [displayed 8 September 2010]. Available at: http://www.hzjz.hr/epidemiologija/hiv.htm
- Zenner D, Tomkins S, Charlett A, Wellings K, Ncube F. HIV prone occupational exposures: epidemiology and factors associated with initiation of post-exposure prophylaxis. J Epidemiol Community Health 2009;63:373-8.
- Taggart S, Breen R, Goldsack N, Sabin C, Johnson M, Lipman M. The changing pattern of bronchoscopy in an HIV-infected population. Chest 2002;122:878-85.
- Centers for Disease Control and Prevention. Updated U. S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis. MMWR 2005 [displayed 8 September 2010]. Available at: http://aidsinfo.nih.gov/contentfiles/HealthCareOccupExpoGL.pdf
- Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997;102(Suppl. 5B):9-15.
- Ippolito G, Puro V, De Carli G; The Italian Study Group on Occupational Risk of HIV infection. The risk of occupational human immunodeficiency virus infection in health care workers. Italian Multicenter Study. Arch Intern Med 1993;153:1451-8.
- Centers for Disease Control and Prevention. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36(Suppl. 2):S1-18.
- Fahey BJ, Koziol DE, Banks SM, Henderson DK. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am J Med 1991;90:145-53.
- Henderson DK, Fahey BJ, Willy M, Schmitt JM, Carey K, Koziol DE, Lane HC, Fedio J, Saah AJ. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med 1990;113:740-6.
- Benn P, Fisher M. HIV and postexposure prophylaxis. Clin Med 2008;8:319-22.
- Lucas MF. [Radiological manifestations of AIDS in the thorax, in Portuguese]. Acta Med Port 1992;5:539-45.
- Marchiori E, Müller NL, Soares Souza A Jr, Escuissato DL, Gasparetto EL, Franquet T. Pulmonary disease in patients with AIDS: high-resolution CT and pathologic findings. AJR Am J Roentgenol 2005;184:757-64.
- Heidenreich PA, Eisenberg MJ, Kee LL, Somelofski CA, Hollander H, Schiller NB, Cheitlin MD. Pericardial effusion in AIDS. Incidence and survival. Circulation 1995;92: 3229-34.
- Khwaja S, Rosenbaum DH, Paul MC, Bhojani RA, Estrera AS, Wait MA, DiMaio JM. Surgical treatment of thoracic empyema in HIV-infected patients: severity and treatment modality is associated with CD4 count status. Chest 2005;128:246-9.
- Sridhar MR, Boopathi S, Lodha R, Kabra SK. Standard precautions and post exposure prophylaxis for preventing infections. Indian J Pediatr 2004;71:617-25.
- Wong ES, Stotka JL, Chinchilli VM, Williams DS, Stuart CG, Markowitz SM. Are universal precautions effective in reducing the number of occupational exposures among health care workers? A prospective study of physicians on a medical service. JAMA 1991;265:1123-8.
- Wu S, Li L, Wu Z, Cao H, Lin C, Yan Z, Jia M, Cui H. Universal precautions in the era of HIV/AIDS: perception of health service providers in Yunnan, China. AIDS Behav 2008;12:806-14.
- Siegel JD, Rhinehart E, Jackson M, Chialrello L; Healthcare Infection Control Practice Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings [displayed 7 September 2010]. Available at http://www.cdc.gov/hicpac/2007IP/2007isolationPrecautions.html
- Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities 2008 [displayed 7 September 2010]. Available at http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/disinfection_nov_2008.pdf